메뉴 건너뛰기




Volumn 120, Issue 1-3, 2012, Pages 190-195

Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians

Author keywords

Abuse; Buprenorphine; Buprenorphine naloxone; Diversion; Post marketing surveillance; Risk management; Suboxone; Survey

Indexed keywords

AMITRIPTYLINE; BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; DIAMORPHINE; METHADONE; OXYCODONE;

EID: 84155164697     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.07.019     Document Type: Article
Times cited : (107)

References (44)
  • 1
    • 84855593292 scopus 로고    scopus 로고
    • AAPCC (American Association of Poison Control Center).
    • AAPCC (American Association of Poison Control Center). http://www.aapcc.org/.
  • 2
    • 33947127824 scopus 로고    scopus 로고
    • Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users
    • Alho H., Sinclair D., Vuori E., Holopainen A. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users. Drug Alcohol Depend. 2007, 88:75-78.
    • (2007) Drug Alcohol Depend. , vol.88 , pp. 75-78
    • Alho, H.1    Sinclair, D.2    Vuori, E.3    Holopainen, A.4
  • 3
    • 0038663019 scopus 로고    scopus 로고
    • Postmarketing surveillance for drug abuse
    • Arfken C., Cicero T. Postmarketing surveillance for drug abuse. Drug Alcohol Depend. 2003, 70:S97-S105.
    • (2003) Drug Alcohol Depend. , vol.70
    • Arfken, C.1    Cicero, T.2
  • 4
    • 0037371928 scopus 로고    scopus 로고
    • Postmarketing surveillance of abuse liability of sibutramine
    • Arfken C., Schuster C., Johanson C.-E. Postmarketing surveillance of abuse liability of sibutramine. Drug Alcohol Depend. 2003, 69:169-173.
    • (2003) Drug Alcohol Depend. , vol.69 , pp. 169-173
    • Arfken, C.1    Schuster, C.2    Johanson, C.-E.3
  • 5
    • 77955095276 scopus 로고    scopus 로고
    • Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians
    • Arfken C., Johanson C.-E., di Menza S., Schuster C. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians. J. Subst. Abuse Treat. 2010, 39:96-104.
    • (2010) J. Subst. Abuse Treat. , vol.39 , pp. 96-104
    • Arfken, C.1    Johanson, C.-E.2    di Menza, S.3    Schuster, C.4
  • 6
    • 0030696977 scopus 로고    scopus 로고
    • Response rates to mail surveys published in medical journals
    • Asch D., Jedrziewski M., Christakis N. Response rates to mail surveys published in medical journals. J. Clin. Epidemiol. 1997, 50:1129-1136.
    • (1997) J. Clin. Epidemiol. , vol.50 , pp. 1129-1136
    • Asch, D.1    Jedrziewski, M.2    Christakis, N.3
  • 8
    • 27244452980 scopus 로고    scopus 로고
    • Potential for abuse of buprenorphine in office-based treatment of opioid dependence
    • Cicero T., Inciardi J. Potential for abuse of buprenorphine in office-based treatment of opioid dependence. N. Engl. J. Med. 2005, 353:1863-1865.
    • (2005) N. Engl. J. Med. , vol.353 , pp. 1863-1865
    • Cicero, T.1    Inciardi, J.2
  • 9
    • 25844526549 scopus 로고    scopus 로고
    • Trends in abuse of oxycontin and other opioid analgesics in the United States: 2002-2004
    • Cicero T., Inciardi J., Munoz A. Trends in abuse of oxycontin and other opioid analgesics in the United States: 2002-2004. J. Pain 2005, 6:662-672.
    • (2005) J. Pain , vol.6 , pp. 662-672
    • Cicero, T.1    Inciardi, J.2    Munoz, A.3
  • 10
    • 27744513872 scopus 로고    scopus 로고
    • Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals
    • Comer S., Sullivan M., Walker E. Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals. J. Pharmacol. Exp. Ther. 2005, 315:1320-1330.
    • (2005) J. Pharmacol. Exp. Ther. , vol.315 , pp. 1320-1330
    • Comer, S.1    Sullivan, M.2    Walker, E.3
  • 11
    • 29244473555 scopus 로고    scopus 로고
    • Major increases in opioid analgesic abuse in the United States: concerns and strategies
    • Compton W., Volkow N. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81:103-107.
    • (2006) Drug Alcohol Depend. , vol.81 , pp. 103-107
    • Compton, W.1    Volkow, N.2
  • 14
    • 84855607295 scopus 로고    scopus 로고
    • DAWN. The DAWN report: trends in emergency department visits involving nonmedical use of narcotic pain relievers. (18.06.10).
    • DAWN, 2010. The DAWN report: trends in emergency department visits involving nonmedical use of narcotic pain relievers. (18.06.10). http://oas.samhsa.gov/2k10/DAWN016/OpioidED.cfm.
    • (2010)
  • 15
    • 0037068511 scopus 로고    scopus 로고
    • Clinical practice. Office-based treatment of opioid-dependent patients
    • Fiellin D., O'Connor P. Clinical practice. Office-based treatment of opioid-dependent patients. N. Engl. J. Med. 2002, 347:817-823.
    • (2002) N. Engl. J. Med. , vol.347 , pp. 817-823
    • Fiellin, D.1    O'Connor, P.2
  • 18
    • 0021101831 scopus 로고
    • Temgesic abuse
    • Harper I. Temgesic abuse. N. Z. Med. J. 1983, 96:777.
    • (1983) N. Z. Med. J. , vol.96 , pp. 777
    • Harper, I.1
  • 20
    • 0018147760 scopus 로고
    • Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction
    • Jasinski D., Pevnick J., Griffith J. Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction. Arch. Gen. Psychiatry 1978, 35:501-516.
    • (1978) Arch. Gen. Psychiatry , vol.35 , pp. 501-516
    • Jasinski, D.1    Pevnick, J.2    Griffith, J.3
  • 21
    • 13844297152 scopus 로고    scopus 로고
    • Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?
    • Jenkinson R., Clark N., Fry C., Dobbin M. Buprenorphine diversion and injection in Melbourne, Australia: an emerging issue?. Addiction 2005, 100:197-205.
    • (2005) Addiction , vol.100 , pp. 197-205
    • Jenkinson, R.1    Clark, N.2    Fry, C.3    Dobbin, M.4
  • 22
    • 0026539226 scopus 로고
    • A controlled trial of buprenorphine treatment for opioid dependence
    • Johnson R., Jaffe J., Fudala P. A controlled trial of buprenorphine treatment for opioid dependence. JAMA 1992, 267:2750-2755.
    • (1992) JAMA , vol.267 , pp. 2750-2755
    • Johnson, R.1    Jaffe, J.2    Fudala, P.3
  • 25
    • 0036768067 scopus 로고    scopus 로고
    • Buprenorphine: blending practice and research
    • Ling W., Smith D. Buprenorphine: blending practice and research. J. Subst. Abuse Treat. 2002, 23:87-92.
    • (2002) J. Subst. Abuse Treat. , vol.23 , pp. 87-92
    • Ling, W.1    Smith, D.2
  • 26
    • 57049118462 scopus 로고    scopus 로고
    • Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty
    • Mark T., Kassed C., Vandivort-Warren R., Levit K., Kranzler H. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009, 99:345-349.
    • (2009) Drug Alcohol Depend. , vol.99 , pp. 345-349
    • Mark, T.1    Kassed, C.2    Vandivort-Warren, R.3    Levit, K.4    Kranzler, H.5
  • 27
    • 84155160614 scopus 로고    scopus 로고
    • SAMHSA Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol, 40. SMA 04-3939. Rockville, MD.
    • McNicholas, L., 2004. SAMHSA Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol, 40. SMA 04-3939. Rockville, MD.
    • (2004)
    • McNicholas, L.1
  • 28
    • 0021952114 scopus 로고
    • Behavioral pharmacology of buprenorphine
    • Mello N., Mendelson J. Behavioral pharmacology of buprenorphine. Drug Alcohol Depend. 1985, 14:283-303.
    • (1985) Drug Alcohol Depend. , vol.14 , pp. 283-303
    • Mello, N.1    Mendelson, J.2
  • 29
    • 0023726538 scopus 로고
    • Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys
    • Mello N., Lukas S., Bree M., Mendelson J. Progressive ratio performance maintained by buprenorphine, heroin and methadone in macaque monkeys. Drug Alcohol Depend. 1988, 21:81-97.
    • (1988) Drug Alcohol Depend. , vol.21 , pp. 81-97
    • Mello, N.1    Lukas, S.2    Bree, M.3    Mendelson, J.4
  • 31
    • 70449652165 scopus 로고    scopus 로고
    • Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence
    • Monte A., Mandell T., Wilford B., Tennyson J., Boyer E. Diversion of buprenorphine/naloxone coformulated tablets in a region with high prescribing prevalence. J. Addict. Dis. 2009, 28:226-231.
    • (2009) J. Addict. Dis. , vol.28 , pp. 226-231
    • Monte, A.1    Mandell, T.2    Wilford, B.3    Tennyson, J.4    Boyer, E.5
  • 32
    • 84855593299 scopus 로고    scopus 로고
    • NFLIS (National Forensic Laboratory Information System). Office of Diversion Control, Drug Enforcement Agency, US Department of Justice, Washington, DC.
    • NFLIS (National Forensic Laboratory Information System). Office of Diversion Control, Drug Enforcement Agency, US Department of Justice, Washington, DC. http://www.deadiversion.usdoj.gov/nflis/index.html.
  • 34
    • 33748776537 scopus 로고    scopus 로고
    • Increasing deaths from opioid analgesics in the United States
    • Paulozzi L., Budnitz D., Xi Y. Increasing deaths from opioid analgesics in the United States. Drug Saf. 2006, 15:618-627.
    • (2006) Drug Saf. , vol.15 , pp. 618-627
    • Paulozzi, L.1    Budnitz, D.2    Xi, Y.3
  • 35
    • 33845327826 scopus 로고    scopus 로고
    • Opioid analgesics and rates of fatal drug poisoning in the United States
    • Paulozzi L., Ryan G. Opioid analgesics and rates of fatal drug poisoning in the United States. Am. J. Prev. Med. 2006, 31:506-511.
    • (2006) Am. J. Prev. Med. , vol.31 , pp. 506-511
    • Paulozzi, L.1    Ryan, G.2
  • 36
    • 0027203690 scopus 로고
    • The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand
    • Robinson G., Dukes P., Robinson B., Cooke R., Mahoney G. The misuse of buprenorphine and a buprenorphine-naloxone combination in Wellington, New Zealand. Drug Alcohol Depend. 1993, 33:81-86.
    • (1993) Drug Alcohol Depend. , vol.33 , pp. 81-86
    • Robinson, G.1    Dukes, P.2    Robinson, B.3    Cooke, R.4    Mahoney, G.5
  • 37
    • 34548433490 scopus 로고    scopus 로고
    • Abuse of buprenorphine in the United States: 2003-2005
    • Smith M., Bailey J., Woody G., Kleber H. Abuse of buprenorphine in the United States: 2003-2005. J. Addict. Dis. 2007, 26:107-111.
    • (2007) J. Addict. Dis. , vol.26 , pp. 107-111
    • Smith, M.1    Bailey, J.2    Woody, G.3    Kleber, H.4
  • 39
    • 84155172254 scopus 로고    scopus 로고
    • TEDS. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Treatment Episode Data Set-Admissions (TEDS-A), 2007 [Computer file]. ICPSR21540-v4. Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI (22.04.10).
    • TEDS, 2007. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Treatment Episode Data Set-Admissions (TEDS-A), 2007 [Computer file]. ICPSR21540-v4. Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI (22.04.10).
    • (2007)
  • 40
    • 84855607276 scopus 로고    scopus 로고
    • TEDS. The TEDS report: characteristics of substance abuse treatment admissions reporting primary abuse of prescription pain relievers: 1998 and 2008. (23.09.10).
    • TEDS, 2010. The TEDS report: characteristics of substance abuse treatment admissions reporting primary abuse of prescription pain relievers: 1998 and 2008. (23.09.10). http://oas.samhsa.gov/2k10/230/230PainRelvr2k10.htm.
    • (2010)
  • 42
    • 0029070494 scopus 로고
    • Acute administration of buprenorphine in humans: partial agonist and blockage effect
    • Walsh S., Preston K., Bigelow G., Stitzer M. Acute administration of buprenorphine in humans: partial agonist and blockage effect. J. Pharmacol. Exp. Ther. 1995, 274:361-372.
    • (1995) J. Pharmacol. Exp. Ther. , vol.274 , pp. 361-372
    • Walsh, S.1    Preston, K.2    Bigelow, G.3    Stitzer, M.4
  • 43
    • 0037987962 scopus 로고    scopus 로고
    • The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic
    • Walsh S., Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003, 70:S13-S27.
    • (2003) Drug Alcohol Depend. , vol.70
    • Walsh, S.1    Eissenberg, T.2
  • 44
    • 0035341938 scopus 로고    scopus 로고
    • The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys
    • Winger G., Woods J. The effects of chronic morphine on behavior reinforced by several opioids or by cocaine in rhesus monkeys. Drug Alcohol Depend. 2001, 62:181-189.
    • (2001) Drug Alcohol Depend. , vol.62 , pp. 181-189
    • Winger, G.1    Woods, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.